The U.S. Government intends to award a sole-source, firm-fixed-price contract to the Oregon Health Authority for newborn screening services to support five Military Treatment Facilities in Guam and Japan. The required service is a comprehensive medical laboratory testing panel covering numerous disorders, with specific additions like Guanidinoacetate methyltransferase deficiency anticipated for Summer 2026 and Mucopolysaccharidosis Type II in early 2027. The justification is that only a state public health authority can provide the integrated testing, case management, and guaranteed lifelong continuity of care required for the transient military population. Capability statements from other sources will be considered only if submitted by 1:00 PM PST on January 30, 2026, to challenge this sole-source determination. This is a notice of intent, not a request for competitive proposals.